68 Ga-NOTA-m-SNA006: A Next-Generation CD8-Targeting Nanobody Probe to Enhance Renal and Hepatic Clearance in Noninvasive ImmunoPET Imaging
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.5c00041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Tukang Peng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 1630 Dongf…. Hauptthemen laut MEDLINE: Gallium Radioisotopes, CD8-Positive T-Lymphocytes, Single-Domain Antibodies, Liver. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Shanghai Jiao Tong University, National Key Research and Development Program of China, Innovative Research Team of High-level Local University in Shanghai.
Abstract (Originalsprache)
The 68Ga-labeled nanobody SNA006 marks a significant advancement in noninvasive immunoPET imaging of CD8+ T cells, facilitating real-time tracking of cellular immune responses in cancer, yet its pharmacokinetic properties remain suboptimal. This study aimed to develop a next-generation CD8-targeting immunoPET nanobody probe by incorporating a PEGylated brush border membrane enzyme-cleavable linker to improve pharmacokinetics and to evaluate its characterization in CD8-positive intrapulmonary tumors. A precursor based on SNA006, containing a PEGylated brush border membrane enzyme-cleavable linker, was designed, synthesized, and radiolabeled with gallium-68 to yield 68Ga-NOTA-m-SNA006. The probe was subsequently assessed both in vitro and in vivo. The probe exhibited high radiochemical yield, purity, and favorable stability, and demonstrated binding to the CD8 protein with high affinity. PET/CT imaging and biodistribution studies revealed that 68Ga-NOTA-m-SNA006 exhibited favorable pharmacokinetic properties, including rapid clearance from the kidneys, reduced liver uptake, and sustained retention in the tumor, compared with 68Ga-NODAGA-SNA006. 68Ga-NOTA-m-SNA006 exhibited high uptake in lung lesions during in vivo PET imaging, reflecting CD8 expression in an intrapulmonary tumor model. In summary, we present a novel 68Ga-labeled SNA006 radiotracer with an optimized linker moiety, 68Ga-NOTA-m-SNA006, which effectively decreases renal and hepatic uptake while maintaining tumor uptake, thereby enhancing the tumor-to-background ratio. This approach represents a critical advancement in addressing the persistent challenge of radioactivity in the kidneys and liver associated with nanobody-based radiopharmaceuticals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 1630 Dongfang Rd, Shanghai 200127, China.
- SmartNuclide Biopharma Co. Ltd., 218 Xinghu St., BioBAY A4-202, Suzhou Industrial Park, Suzhou 215123, China.
- College of Chemistry and Materials Science, Shanghai Normal University, Shanghai 210000, China.
- Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China.
ORCID-Profile: Tukang Peng, Jianjun Liu, Haitao Zhao
Förderung
- Shanghai Jiao Tong University
- National Key Research and Development Program of China
- Innovative Research Team of High-level Local University in Shanghai
- National Natural Science Foundation of China
Zitieren
APA
Peng, T., Wang, C., Wen, J., Zhang, Q., Wang, C., Lv, C., Du, F., Hu, Z., Xu, T., Huang, G., Liu, J., & Zhao, H. (2025). 68 Ga-NOTA-m-SNA006: A Next-Generation CD8-Targeting Nanobody Probe to Enhance Renal and Hepatic Clearance in Noninvasive ImmunoPET Imaging. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00041
Vancouver
Peng T, Wang C, Wen J, Zhang Q, Wang C, Lv C, et al. 68 Ga-NOTA-m-SNA006: A Next-Generation CD8-Targeting Nanobody Probe to Enhance Renal and Hepatic Clearance in Noninvasive ImmunoPET Imaging. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00041
BibTeX
@article{Peng2025,
author = {Peng, Tukang and Wang, Chao and Wen, Jun and Zhang, Qingyu and Wang, Cheng and Lv, Chun and Du, Fuqiang and Hu, Zhoumi and Xu, Tao and Huang, Gang and Liu, Jianjun and Zhao, Haitao},
title = {68 Ga-NOTA-m-SNA006: A Next-Generation CD8-Targeting Nanobody Probe to Enhance Renal and Hepatic Clearance in Noninvasive ImmunoPET Imaging},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.5c00041}
}
EUVIMED